Vimarsana
Biggest News Aggregation in the World

Page 2 - Plight Chain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Plight Chain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Plight Chain Today - Breaking & Trending Today

Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting - Vimarsana News

Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting

– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease to be Presented at International Conference – – Baseline Biomarker Data to be Presented from Ongoing ATH434-201...

Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 ... - Vimarsana News

Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 ...

– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease to be Presented at International Conference –

UniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington's Disease -December 19, 2023 at 07:05 am EST - Vimarsana News

UniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington's Disease -December 19, 2023 at 07:05 am EST

~ Patients treated with AMT-130 continue to show evidence of preserved neurological function with potential dose-dependent clinical benefits relative to an inclusion criteria-matched natural...

UniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington's Disease -December 19, 2023 at 07:06 am EST - Vimarsana News

UniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington's Disease -December 19, 2023 at 07:06 am EST

~ Patients treated with AMT-130 continue to show evidence of preserved neurological function with potential dose-dependent clinical benefits relative to an inclusion criteria-matched natural...

AstraZeneca advances scientific leadership in hematology at ASH 2023 - Vimarsana News

AstraZeneca advances scientific leadership in hematology at ASH 2023

CALQUENCE six-year follow-up data reinforce long-term benefit in chronic lymphocytic leukemia, and data across multiple hematology assets showcase breadth of promising early pipeline New,...